Swiv

British Journal of Cancer - AOP - nature.com science feeds

The BJC is owned by Cancer Research UK, a charity dedicated to understanding the causes, prevention and treatment of cancer and to making sure that the best new treatments reach patients in the clinic as quickly as possible. The journal reflects these aims. It was founded more than fifty years ago and, from the start, its far-sighted mission was to encourage communication of the very best cancer research from laboratories and clinics in all countries. The breadth of its coverage, its editorial independence and it consistent high standards, have made BJC one of the world's premier general cancer journals. Its increasing popularity is reflected by a steadily rising impact factor.

http://www.nature.com/bjc/journal/vaop/ncurrent/rss.rdf
http://swiv.eu/british-journal-of-cancer-aop-nature-com-s_160.xml feed
Add to your feed

The cap-translation inhibitor 4EGI-1 induces apoptosis in multiple myeloma through Noxa induction Quick resume for : The cap-translation inhibitor 4EGI-1 induces apoptosis in multiple myeloma through Noxa induction

17.04.2012 00:00

Skeletal muscle anabolism is a side effect of therapy with the MEK inhibitor: selumetinib in patients with cholangiocarcinoma Quick resume for : Skeletal muscle anabolism is a side effect of therapy with the MEK inhibitor: selumetinib in patients with cholangiocarcinoma

17.04.2012 00:00

The HIF-pathway inhibitor NSC-134754 induces metabolic changes and anti-tumour activity while maintaining vascular function Quick resume for : The HIF-pathway inhibitor NSC-134754 induces metabolic changes and anti-tumour activity while maintaining vascular function

12.04.2012 00:00

Apoptosome-dependent caspase activation proteins as prognostic markers in Stage II and III colorectal cancer Quick resume for : Apoptosome-dependent caspase activation proteins as prognostic markers in Stage II and III colorectal cancer

05.04.2012 00:00

Evidence for under-diagnosis of childhood acute lymphoblastic leukaemia in poorer communities within Great Britain Quick resume for : Evidence for under-diagnosis of childhood acute lymphoblastic leukaemia in poorer communities within Great Britain

03.04.2012 00:00

Negative argininosuccinate synthetase expression in melanoma tumours may predict clinical benefit from arginine-depleting therapy with pegylated arginine deiminase Quick resume for : Negative argininosuccinate synthetase expression in melanoma tumours may predict clinical benefit from arginine-depleting therapy with pegylated arginine deiminase

03.04.2012 00:00

Personalised cancer follow-up: risk stratification, needs assessment or both? Quick resume for : Personalised cancer follow-up: risk stratification, needs assessment or both?

03.04.2012 00:00

The role of miRNAs in human papilloma virus (HPV)-associated cancers: bridging between HPV-related head and neck cancer and cervical cancer Quick resume for : The role of miRNAs in human papilloma virus (HPV)-associated cancers: bridging between HPV-related head and neck cancer and cervical cancer

03.04.2012 00:00

Dynamic equilibrium between cancer stem cells and non-stem cancer cells in human SW620 and MCF-7 cancer cell populations Quick resume for : Dynamic equilibrium between cancer stem cells and non-stem cancer cells in human SW620 and MCF-7 cancer cell populations

03.04.2012 00:00

PPARgamma inhibits hepatocellular carcinoma metastases in vitro and in mice Quick resume for : PPARgamma inhibits hepatocellular carcinoma metastases in vitro and in mice

03.04.2012 00:00

Mitochondrial D310 mutations in the early development of breast cancer Quick resume for : Mitochondrial D310 mutations in the early development of breast cancer

03.04.2012 00:00

MMP-2 and MMP-9 in normal mucosa are independently associated with outcome of colorectal cancer patients Quick resume for : MMP-2 and MMP-9 in normal mucosa are independently associated with outcome of colorectal cancer patients

03.04.2012 00:00

Impact of mutant β-catenin on ABCB1 expression and therapy response in colon cancer cells Quick resume for : Impact of mutant β-catenin on ABCB1 expression and therapy response in colon cancer cells

29.03.2012 00:00

Expression of sphingosine 1-phosphate receptor 4 and sphingosine kinase 1 is associated with outcome in oestrogen receptor-negative breast cancer Quick resume for : Expression of sphingosine 1-phosphate receptor 4 and sphingosine kinase 1 is associated with outcome in oestrogen receptor-negative breast cancer

29.03.2012 00:00

Randomised phase II trial of docetaxel and sunitinib in patients with metastatic gastric cancer who were previously treated with fluoropyrimidine and platinum Quick resume for : Randomised phase II trial of docetaxel and sunitinib in patients with metastatic gastric cancer who were previously treated with fluoropyrimidine and platinum

29.03.2012 00:00

Use of Aspirin postdiagnosis improves survival for colon cancer patients Quick resume for : Use of Aspirin postdiagnosis improves survival for colon cancer patients

27.03.2012 00:00

NT5E (CD73) is epigenetically regulated in malignant melanoma and associated with metastatic site specificity Quick resume for : NT5E (CD73) is epigenetically regulated in malignant melanoma and associated with metastatic site specificity

27.03.2012 00:00

Comparison and combination of blood-based inflammatory markers with faecal occult blood tests for non-invasive colorectal cancer screening Quick resume for : Comparison and combination of blood-based inflammatory markers with faecal occult blood tests for non-invasive colorectal cancer screening

27.03.2012 00:00

Increased signalling of EGFR and IGF1R, and deregulation of PTEN/PI3K/Akt pathway are related with trastuzumab resistance in HER2 breast carcinomas Quick resume for : Increased signalling of EGFR and IGF1R, and deregulation of PTEN/PI3K/Akt pathway are related with trastuzumab resistance in HER2 breast carcinomas

27.03.2012 00:00

Cost-effectiveness of cervical cancer screening with primary human papillomavirus testing in Norway Quick resume for : Cost-effectiveness of cervical cancer screening with primary human papillomavirus testing in Norway

22.03.2012 00:00

Everolimus in metastatic renal cell carcinoma patients intolerant to previous VEGFr-TKI therapy: a RECORD-1 subgroup analysis Quick resume for : Everolimus in metastatic renal cell carcinoma patients intolerant to previous VEGFr-TKI therapy: a RECORD-1 subgroup analysis

22.03.2012 00:00

High expression of Lin28 is associated with tumour aggressiveness and poor prognosis of patients in oesophagus cancer Quick resume for : High expression of Lin28 is associated with tumour aggressiveness and poor prognosis of patients in oesophagus cancer

20.03.2012 00:00

A novel, externally validated inflammation-based prognostic algorithm in hepatocellular carcinoma: the prognostic nutritional index (PNI) Quick resume for : A novel, externally validated inflammation-based prognostic algorithm in hepatocellular carcinoma: the prognostic nutritional index (PNI)

20.03.2012 00:00

Serum matrix metalloproteinase 9 and colorectal neoplasia: a community-based evaluation of a potential diagnostic test Quick resume for : Serum matrix metalloproteinase 9 and colorectal neoplasia: a community-based evaluation of a potential diagnostic test

20.03.2012 00:00

Loss of partner and breast cancer prognosis — a population-based study, Denmark, 1994–2010 Quick resume for : Loss of partner and breast cancer prognosis — a population-based study, Denmark, 1994–2010

20.03.2012 00:00

Survival advantage observed with the use of metformin in patients with type II diabetes and colorectal cancer Quick resume for : Survival advantage observed with the use of metformin in patients with type II diabetes and colorectal cancer

15.03.2012 00:00

Mutation analysis of RAD51D in non-BRCA1/2 ovarian and breast cancer families Quick resume for : Mutation analysis of RAD51D in non-BRCA1/2 ovarian and breast cancer families

13.03.2012 00:00

Reply: Metronomic chemotherapy with cyclophosphamide and dexamethasone in patients with metastatic carcinoma of the prostate Quick resume for : Reply: Metronomic chemotherapy with cyclophosphamide and dexamethasone in patients with metastatic carcinoma of the prostate

13.03.2012 00:00

How many strata in an RCT? A flexible approach Quick resume for : How many strata in an RCT? A flexible approach

13.03.2012 00:00

Impact of genomic stability on protein expression in endometrioid endometrial cancer Quick resume for : Impact of genomic stability on protein expression in endometrioid endometrial cancer

13.03.2012 00:00

Metronomic chemotherapy with cyclophosphamide and dexamethasone in patients with metastatic carcinoma of the prostate Quick resume for : Metronomic chemotherapy with cyclophosphamide and dexamethasone in patients with metastatic carcinoma of the prostate

13.03.2012 00:00

Loss of GPER identifies new targets for therapy among a subgroup of ERα-positive endometrial cancer patients with poor outcome Quick resume for : Loss of GPER identifies new targets for therapy among a subgroup of ERα-positive endometrial cancer patients with poor outcome

13.03.2012 00:00

Detection of Merkel cell virus and correlation with histologic presence of Merkel cell carcinoma in sentinel lymph nodes Quick resume for : Detection of Merkel cell virus and correlation with histologic presence of Merkel cell carcinoma in sentinel lymph nodes

13.03.2012 00:00

Magnesium intake, plasma C-peptide, and colorectal cancer incidence in US women: a 28-year follow-up study Quick resume for : Magnesium intake, plasma C-peptide, and colorectal cancer incidence in US women: a 28-year follow-up study

13.03.2012 00:00

Safety of UFT/LV and S-1 as adjuvant therapy for stage III colon cancer in phase III trial: ACTS-CC trial Quick resume for : Safety of UFT/LV and S-1 as adjuvant therapy for stage III colon cancer in phase III trial: ACTS-CC trial

13.03.2012 00:00

The Aarhus statement: improving design and reporting of studies on early cancer diagnosis Quick resume for : The Aarhus statement: improving design and reporting of studies on early cancer diagnosis

13.03.2012 00:00

The synergistic interaction of MEK and PI3K inhibitors is modulated by mTOR inhibition Quick resume for : The synergistic interaction of MEK and PI3K inhibitors is modulated by mTOR inhibition

13.03.2012 00:00

The chemokine, CXCL12, is an independent predictor of poor survival in ovarian cancer Quick resume for : The chemokine, CXCL12, is an independent predictor of poor survival in ovarian cancer

13.03.2012 00:00

Major ethnic group differences in breast cancer screening uptake in Scotland are not extinguished by adjustment for indices of geographical residence, area deprivation, long-term illness and education Quick resume for : Major ethnic group differences in breast cancer screening uptake in Scotland are not extinguished by adjustment for indices of geographical residence, area deprivation, long-term illness and education

13.03.2012 00:00

Effects of erythropoietin receptors and erythropoiesis-stimulating agents on disease progression in cancer Quick resume for : Effects of erythropoietin receptors and erythropoiesis-stimulating agents on disease progression in cancer

06.03.2012 00:00

Fas/Fas ligand regulation mediates cell death in human Ewing's sarcoma cells treated with melatonin Quick resume for : Fas/Fas ligand regulation mediates cell death in human Ewing's sarcoma cells treated with melatonin

01.03.2012 00:00

Variation in advanced stage at diagnosis of lung and female breast cancer in an English region 2006–2009 Quick resume for : Variation in advanced stage at diagnosis of lung and female breast cancer in an English region 2006–2009

01.03.2012 00:00

Predicting the safety and efficacy of buffer therapy to raise tumour pHe: an integrative modelling study Quick resume for : Predicting the safety and efficacy of buffer therapy to raise tumour pHe: an integrative modelling study

01.03.2012 00:00

Repeated transarterial chemoembolisation using different chemotherapeutic drug combinations followed by MR-guided laser-induced thermotherapy in patients with liver metastases of colorectal carcinoma Quick resume for : Repeated transarterial chemoembolisation using different chemotherapeutic drug combinations followed by MR-guided laser-induced thermotherapy in patients with liver metastases of colorectal carcinoma

01.03.2012 00:00

Multicentre phase II trial of trastuzumab and capecitabine in patients with HER2 overexpressing metastatic pancreatic cancer Quick resume for : Multicentre phase II trial of trastuzumab and capecitabine in patients with HER2 overexpressing metastatic pancreatic cancer

28.02.2012 00:00

Cancer-specific survival after radical nephroureterectomy for upper urinary tract urothelial carcinoma: proposal and multi-institutional validation of a post-operative nomogram Quick resume for : Cancer-specific survival after radical nephroureterectomy for upper urinary tract urothelial carcinoma: proposal and multi-institutional validation of a post-operative nomogram

28.02.2012 00:00

The cost-effectiveness of screening lung cancer patients for targeted drug sensitivity markers Quick resume for : The cost-effectiveness of screening lung cancer patients for targeted drug sensitivity markers

28.02.2012 00:00

The ganglioside antigen GD2 is surface-expressed in Ewing sarcoma and allows for MHC-independent immune targeting Quick resume for : The ganglioside antigen GD2 is surface-expressed in Ewing sarcoma and allows for MHC-independent immune targeting

28.02.2012 00:00

Increasing response rates from physicians in oncology research: a structured literature review and data from a recent physician survey Quick resume for : Increasing response rates from physicians in oncology research: a structured literature review and data from a recent physician survey

28.02.2012 00:00

Uterine artery pulsatility index: a predictor of methotrexate resistance in gestational trophoblastic neoplasia Quick resume for : Uterine artery pulsatility index: a predictor of methotrexate resistance in gestational trophoblastic neoplasia

28.02.2012 00:00

Biglycan is a specific marker and an autocrine angiogenic factor of tumour endothelial cells Quick resume for : Biglycan is a specific marker and an autocrine angiogenic factor of tumour endothelial cells

28.02.2012 00:00

Prognostic value of a cell cycle progression signature for prostate cancer death in a conservatively managed needle biopsy cohort Quick resume for : Prognostic value of a cell cycle progression signature for prostate cancer death in a conservatively managed needle biopsy cohort

23.02.2012 00:00

HER2/neu and Ki-67 expression predict non-invasive recurrence following breast-conserving therapy for ductal carcinoma in situ Quick resume for : HER2/neu and Ki-67 expression predict non-invasive recurrence following breast-conserving therapy for ductal carcinoma in situ

23.02.2012 00:00

Phenformin as prophylaxis and therapy in breast cancer xenografts Quick resume for : Phenformin as prophylaxis and therapy in breast cancer xenografts

23.02.2012 00:00

Hedgehog pathway activation in human transitional cell carcinoma of the bladder Quick resume for : Hedgehog pathway activation in human transitional cell carcinoma of the bladder

23.02.2012 00:00

Creation of immortalised epithelial cells from ovarian endometrioma Quick resume for : Creation of immortalised epithelial cells from ovarian endometrioma

21.02.2012 00:00

Prognostic significance of chromosome 3 alterations determined by microsatellite analysis in uveal melanoma: a long-term follow-up study Quick resume for : Prognostic significance of chromosome 3 alterations determined by microsatellite analysis in uveal melanoma: a long-term follow-up study

21.02.2012 00:00

The interrelationships between Src, Cav-1 and RhoGD12 in transitional cell carcinoma of the bladder Quick resume for : The interrelationships between Src, Cav-1 and RhoGD12 in transitional cell carcinoma of the bladder

21.02.2012 00:00

A web-based prognostic tool for extremity and trunk wall soft tissue sarcomas and its external validation Quick resume for : A web-based prognostic tool for extremity and trunk wall soft tissue sarcomas and its external validation

21.02.2012 00:00

Microsatellite instability and Beta2-Microglobulin mutations as prognostic markers in colon cancer: results of the FOGT-4 trial Quick resume for : Microsatellite instability and Beta2-Microglobulin mutations as prognostic markers in colon cancer: results of the FOGT-4 trial

21.02.2012 00:00

Long-term assessment of quality of life in the Intergroup Exemestane Study: 5 years post-randomisation Quick resume for : Long-term assessment of quality of life in the Intergroup Exemestane Study: 5 years post-randomisation

21.02.2012 00:00

First-line chemotherapy with liposomal doxorubicin plus cisplatin for patients with advanced malignant pleural mesothelioma: phase II trial Quick resume for : First-line chemotherapy with liposomal doxorubicin plus cisplatin for patients with advanced malignant pleural mesothelioma: phase II trial

21.02.2012 00:00

Detection and characterisation of multi-drug resistance protein 1 (MRP-1) in human mitochondria Quick resume for : Detection and characterisation of multi-drug resistance protein 1 (MRP-1) in human mitochondria

21.02.2012 00:00

Comorbidity in elderly cancer patients in relation to overall and cancer-specific mortality Quick resume for : Comorbidity in elderly cancer patients in relation to overall and cancer-specific mortality

21.02.2012 00:00

Analysis of circulating angiogenic biomarkers from patients in two phase III trials in lung cancer of chemotherapy alone or chemotherapy and thalidomide Quick resume for : Analysis of circulating angiogenic biomarkers from patients in two phase III trials in lung cancer of chemotherapy alone or chemotherapy and thalidomide

21.02.2012 00:00

Adjuvant! Online or comprehensive geriatric assessment for women over 70 years with primary breast cancer? Quick resume for : Adjuvant! Online or comprehensive geriatric assessment for women over 70 years with primary breast cancer?

16.02.2012 00:00

Effect of κ-opioid receptor agonist on the growth of non-small cell lung cancer (NSCLC) cells Quick resume for : Effect of κ-opioid receptor agonist on the growth of non-small cell lung cancer (NSCLC) cells

16.02.2012 00:00

Phase II study of everolimus with biomarker exploration in patients with advanced gastric cancer refractory to chemotherapy including fluoropyrimidine and platinum Quick resume for : Phase II study of everolimus with biomarker exploration in patients with advanced gastric cancer refractory to chemotherapy including fluoropyrimidine and platinum

16.02.2012 00:00

No evidence for the involvement of XMRV or MCV in the pathogenesis of breast cancer Quick resume for : No evidence for the involvement of XMRV or MCV in the pathogenesis of breast cancer

16.02.2012 00:00

A network-based, integrative study to identify core biological pathways that drive breast cancer clinical subtypes Quick resume for : A network-based, integrative study to identify core biological pathways that drive breast cancer clinical subtypes

16.02.2012 00:00

The MEK1/2 inhibitor, selumetinib (AZD6244; ARRY-142886), enhances anti-tumour efficacy when combined with conventional chemotherapeutic agents in human tumour xenograft models Quick resume for : The MEK1/2 inhibitor, selumetinib (AZD6244; ARRY-142886), enhances anti-tumour efficacy when combined with conventional chemotherapeutic agents in human tumour xenograft models

16.02.2012 00:00

Childhood infections, orchitis and testicular germ cell tumours: a report from the STEED study and a meta-analysis of existing data Quick resume for : Childhood infections, orchitis and testicular germ cell tumours: a report from the STEED study and a meta-analysis of existing data

16.02.2012 00:00

Cost-effectiveness of population-based screening for colorectal cancer: a comparison of guaiac-based faecal occult blood testing, faecal immunochemical testing and flexible sigmoidoscopy Quick resume for : Cost-effectiveness of population-based screening for colorectal cancer: a comparison of guaiac-based faecal occult blood testing, faecal immunochemical testing and flexible sigmoidoscopy

16.02.2012 00:00

Aberrant activation of the mTOR pathway and anti-tumour effect of everolimus on oesophageal squamous cell carcinoma Quick resume for : Aberrant activation of the mTOR pathway and anti-tumour effect of everolimus on oesophageal squamous cell carcinoma

14.02.2012 00:00

Carbonic anhydrase IX is a predictive marker of doxorubicin resistance in early-stage breast cancer independent of HER2 and TOP2A amplification Quick resume for : Carbonic anhydrase IX is a predictive marker of doxorubicin resistance in early-stage breast cancer independent of HER2 and TOP2A amplification

14.02.2012 00:00

Enzastaurin has anti-tumour effects in lung cancers with overexpressed JAK pathway molecules Quick resume for : Enzastaurin has anti-tumour effects in lung cancers with overexpressed JAK pathway molecules

14.02.2012 00:00

BRCA1 testing should be offered to individuals with triple-negative breast cancer diagnosed below 50 years Quick resume for : BRCA1 testing should be offered to individuals with triple-negative breast cancer diagnosed below 50 years

14.02.2012 00:00

Overexpression of PFTK1 predicts resistance to chemotherapy in patients with oesophageal squamous cell carcinoma Quick resume for : Overexpression of PFTK1 predicts resistance to chemotherapy in patients with oesophageal squamous cell carcinoma

14.02.2012 00:00

Long-term CIN3+ risk in women with abnormal cytology; role of hrHPV testing Quick resume for : Long-term CIN3+ risk in women with abnormal cytology; role of hrHPV testing

14.02.2012 00:00

A cohort study of the prognostic and treatment predictive value of SATB2 expression in colorectal cancer Quick resume for : A cohort study of the prognostic and treatment predictive value of SATB2 expression in colorectal cancer

14.02.2012 00:00

A phase I trial of pan-Bcl-2 antagonist obatoclax administered as a 3-h or a 24-h infusion in combination with carboplatin and etoposide in patients with extensive-stage small cell lung cancer Quick resume for : A phase I trial of pan-Bcl-2 antagonist obatoclax administered as a 3-h or a 24-h infusion in combination with carboplatin and etoposide in patients with extensive-stage small cell lung cancer

14.02.2012 00:00

Cancer stem cell phenotype relates to radio-chemotherapy outcome in locally advanced squamous cell head–neck cancer Quick resume for : Cancer stem cell phenotype relates to radio-chemotherapy outcome in locally advanced squamous cell head–neck cancer

14.02.2012 00:00

A phase 1 trial of recombinant human IL-21 in combination with cetuximab in patients with metastatic colorectal cancer Quick resume for : A phase 1 trial of recombinant human IL-21 in combination with cetuximab in patients with metastatic colorectal cancer

07.02.2012 00:00

Immunohistochemical discrimination of wild-type EGFR from EGFRvIII in fixed tumour specimens using anti-EGFR mAbs ICR9 and ICR10 Quick resume for : Immunohistochemical discrimination of wild-type EGFR from EGFRvIII in fixed tumour specimens using anti-EGFR mAbs ICR9 and ICR10

07.02.2012 00:00

Pre-treatment lactate dehydrogenase levels as predictor of efficacy of first-line bevacizumab-based therapy in metastatic colorectal cancer patients Quick resume for : Pre-treatment lactate dehydrogenase levels as predictor of efficacy of first-line bevacizumab-based therapy in metastatic colorectal cancer patients

07.02.2012 00:00

Malignant mesotheliomas in former miners and millers of crocidolite at Wittenoom (Western Australia) after more than 50 years follow-up Quick resume for : Malignant mesotheliomas in former miners and millers of crocidolite at Wittenoom (Western Australia) after more than 50 years follow-up

07.02.2012 00:00

Acquisition of EMT phenotype in the gefitinib-resistant cells of a head and neck squamous cell carcinoma cell line through Akt/GSK-3β/snail signalling pathway Quick resume for : Acquisition of EMT phenotype in the gefitinib-resistant cells of a head and neck squamous cell carcinoma cell line through Akt/GSK-3β/snail signalling pathway

07.02.2012 00:00

Socioeconomic position, treatment, and survival of non-Hodgkin lymphoma in Denmark – a nationwide study Quick resume for : Socioeconomic position, treatment, and survival of non-Hodgkin lymphoma in Denmark – a nationwide study

07.02.2012 00:00

Direct improvement of quality of life using a tailored quality of life diagnosis and therapy pathway: randomised trial in 200 women with breast cancer Quick resume for : Direct improvement of quality of life using a tailored quality of life diagnosis and therapy pathway: randomised trial in 200 women with breast cancer

07.02.2012 00:00

Circulating sphingosine-1-phosphate and erythrocyte sphingosine kinase-1 activity as novel biomarkers for early prostate cancer detection Quick resume for : Circulating sphingosine-1-phosphate and erythrocyte sphingosine kinase-1 activity as novel biomarkers for early prostate cancer detection

07.02.2012 00:00

Prognostic significance of gamma-glutamyltransferase in patients with endometrial cancer: a multi-centre trial Quick resume for : Prognostic significance of gamma-glutamyltransferase in patients with endometrial cancer: a multi-centre trial

07.02.2012 00:00

Concentrations of IGF-I and IGFBP-3 and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition Quick resume for : Concentrations of IGF-I and IGFBP-3 and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition

07.02.2012 00:00

Supernatants derived from chemotherapy-treated cancer cell lines can modify angiogenesis Quick resume for : Supernatants derived from chemotherapy-treated cancer cell lines can modify angiogenesis

31.01.2012 00:00

Severe toxicity caused by sorafenib in hepatocellular carcinoma match the data from renal cell carcinoma Quick resume for : Severe toxicity caused by sorafenib in hepatocellular carcinoma match the data from renal cell carcinoma

31.01.2012 00:00

The association of statins and taxanes: an efficient combination trigger of cancer cell apoptosis Quick resume for : The association of statins and taxanes: an efficient combination trigger of cancer cell apoptosis

31.01.2012 00:00

Clinical significance of CD151 overexpression in subtypes of invasive breast cancer Quick resume for : Clinical significance of CD151 overexpression in subtypes of invasive breast cancer

31.01.2012 00:00

Skin cancer screening participation and impact on melanoma incidence in Germany – an observational study on incidence trends in regions with and without population-based screening Quick resume for : Skin cancer screening participation and impact on melanoma incidence in Germany – an observational study on incidence trends in regions with and without population-based screening

31.01.2012 00:00

Pre-treatment plasma proteomic markers associated with survival in oesophageal cancer Quick resume for : Pre-treatment plasma proteomic markers associated with survival in oesophageal cancer

31.01.2012 00:00

Serum 20S proteasome is elevated in patients with renal cell carcinoma and associated with poor prognosis Quick resume for : Serum 20S proteasome is elevated in patients with renal cell carcinoma and associated with poor prognosis

31.01.2012 00:00

Functional imaging: what evidence is there for its utility in clinical trials of targeted therapies? Quick resume for : Functional imaging: what evidence is there for its utility in clinical trials of targeted therapies?

26.01.2012 00:00

Relationship between breast cancer risk factors and mammographic breast density in the Fernald Community Cohort Quick resume for : Relationship between breast cancer risk factors and mammographic breast density in the Fernald Community Cohort

26.01.2012 00:00

Tumour growth kinetics assessment: added value to RECIST in cancer patients treated with molecularly targeted agents Quick resume for : Tumour growth kinetics assessment: added value to RECIST in cancer patients treated with molecularly targeted agents

26.01.2012 00:00

Mutation analysis of BRAF and KIT in circulating melanoma cells at the single cell level Quick resume for : Mutation analysis of BRAF and KIT in circulating melanoma cells at the single cell level

26.01.2012 00:00

Exposure to animals and increased risk of marginal zone B-cell lymphomas of the ocular adnexae Quick resume for : Exposure to animals and increased risk of marginal zone B-cell lymphomas of the ocular adnexae

24.01.2012 00:00

Survival gains needed to offset persistent adverse treatment effects in localised prostate cancer Quick resume for : Survival gains needed to offset persistent adverse treatment effects in localised prostate cancer

24.01.2012 00:00

Cytochrome-c mediated a bystander response dependent on inducible nitric oxide synthase in irradiated hepatoma cells Quick resume for : Cytochrome-c mediated a bystander response dependent on inducible nitric oxide synthase in irradiated hepatoma cells

24.01.2012 00:00

Internet chemotherapy information: impact on patients and health professionals Quick resume for : Internet chemotherapy information: impact on patients and health professionals

19.01.2012 00:00

Detection of gastric cancer-associated microRNAs on microRNA microarray comparing pre- and post-operative plasma Quick resume for : Detection of gastric cancer-associated microRNAs on microRNA microarray comparing pre- and post-operative plasma

19.01.2012 00:00

HPV DNA testing in population-based cervical screening (VUSA-Screen study): results and implications Quick resume for : HPV DNA testing in population-based cervical screening (VUSA-Screen study): results and implications

17.01.2012 00:00

Sigma-2 ligands induce tumour cell death by multiple signalling pathways Quick resume for : Sigma-2 ligands induce tumour cell death by multiple signalling pathways

17.01.2012 00:00

Combined effect of ALK and MEK inhibitors in EML4–ALK-positive non-small-cell lung cancer cells Quick resume for : Combined effect of ALK and MEK inhibitors in EML4–ALK-positive non-small-cell lung cancer cells

12.01.2012 00:00

Lung cancer in the Swiss HIV Cohort Study: role of smoking, immunodeficiency and pulmonary infection Quick resume for : Lung cancer in the Swiss HIV Cohort Study: role of smoking, immunodeficiency and pulmonary infection

12.01.2012 00:00

Triplets versus doublets, with or without cisplatin, in the first-line treatment of stage IIIB–IV non-small cell lung cancer (NSCLC) patients: a multicenter randomised factorial trial (FAST) Quick resume for : Triplets versus doublets, with or without cisplatin, in the first-line treatment of stage IIIB–IV non-small cell lung cancer (NSCLC) patients: a multicenter randomised factorial trial (FAST)

12.01.2012 00:00

Features of childhood cancer in primary care: a population-based nested case–control study Quick resume for : Features of childhood cancer in primary care: a population-based nested case–control study

12.01.2012 00:00

Open-label feasibility study of pazopanib, carboplatin, and paclitaxel in women with newly diagnosed, untreated, gynaecologic tumours: a phase I/II trial of the AGO study group Quick resume for : Open-label feasibility study of pazopanib, carboplatin, and paclitaxel in women with newly diagnosed, untreated, gynaecologic tumours: a phase I/II trial of the AGO study group

12.01.2012 00:00

Phase I first-in-human study of TAK-285, a novel investigational dual HER2/EGFR inhibitor, in cancer patients Quick resume for : Phase I first-in-human study of TAK-285, a novel investigational dual HER2/EGFR inhibitor, in cancer patients

12.01.2012 00:00

Serum biomarker panels for the diagnosis of gastric adenocarcinoma Quick resume for : Serum biomarker panels for the diagnosis of gastric adenocarcinoma

12.01.2012 00:00

Risk profiles of prostate cancers identified from UK primary care using national referral guidelines Quick resume for : Risk profiles of prostate cancers identified from UK primary care using national referral guidelines

12.01.2012 00:00

The BH3 mimetic HA14-1 enhances 5-fluorouracil-induced autophagy and type II cell death in oesophageal cancer cells Quick resume for : The BH3 mimetic HA14-1 enhances 5-fluorouracil-induced autophagy and type II cell death in oesophageal cancer cells

12.01.2012 00:00

Randomised phase-II trial of CAPIRI (capecitabine, irinotecan) plus bevacizumab vs FOLFIRI (folinic acid, 5-fluorouracil, irinotecan) plus bevacizumab as first-line treatment of patients with unresectable/metastatic colorectal cancer (mCRC) Quick resume for : Randomised phase-II trial of CAPIRI (capecitabine, irinotecan) plus bevacizumab vs FOLFIRI (folinic acid, 5-fluorouracil, irinotecan) plus bevacizumab as first-line treatment of patients with unresectable/metastatic colorectal cancer (mCRC)

12.01.2012 00:00

Swiv Logo Swiv.eu, watch site informative for RSS feed management

RSS (Image)SWIV combines the flow of information to ensure you get a relevant and effective through a personalized RSS feed.

Options
You're SWIV. › Liste des publications en cancérologie
Home
You are not logged.
Login  Create an account
 
Create a feed
Advertisements
RSS feeds
Flows SWIV
 
Enter your info
Create a feed
 
Search
Submit a feed
Thematic flow
Form of new flows

If you want to help us build a new RSS feed from existing resources, not the form of an RSS feed published on the Web, you can send us a message. Lay out all the necessary information and your email address, we will keep you informed (e) of the process. Applications clearly out-about will be ignored.

Liste des publications en cancérologieUtilisateur Cancer Cancer (homonymie) Recherche en cancérologie Tourteau (crabe) Cancer (genre) Fred Hutchinson cancer research center Cancer Research BJC Cancer du sein Liste des cancers National Cancer Institute
Entry Points
»
Close

Click on the address to select it. Click copy and then paste it into your preferred reader.

Close
Close
Languages
bg cs da de el en es et fi fr gr hu it lt lv mt nl pl pt sk sl sv
Font size
Boxes position
Close
Imprint | Right
© 2006 - 2012 Lexeek, All rights reserved